BLADDER EPITHELIAL CELLS FROM PATIENTS WITH INTERSTITIAL CYSTITIS PRODUCE AN INHIBITOR OF HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR PRODUCTION
Abstract
Purpose:
The etiology of interstitial cystitis is unknown. We previously identified an interstitial cystitis urine factor, antiproliferative factor, that inhibits proliferation of bladder epithelial cells in vitro and complex changes in epithelial growth factor levels, including profound decreases in heparin-binding epidermal growth factor-like growth factor (HB-EGF). Bladder and renal pelvic catheterization of patients with interstitial cystitis indicated that the antiproliferative factor is made and/or activated in the distal ureter or bladder. Therefore, we determined whether bladder epithelial cells from interstitial cystitis cases produced the antiproliferative factor and whether purified antiproliferative factor could alter production of growth factors known to be abnormal in interstitial cystitis.
Materials and Methods:
Antiproliferative factor activity was determined by 3H-thymidine incorporation into primary bladder epithelial cells. The antiproliferative factor was purified by size fractionation followed by sequential chromatography involving ion exchange, hydrophobic interaction and high performance liquid chromatography. HB-EGF, epidermal growth factor, insulin-like growth factor and insulin-like growth factor binding protein 3 levels were determined by enzyme-linked immunosorbent assay.
Results:
Bladder epithelial cells from patients with interstitial cystitis produced a single antiproliferative factor with the same purification profile as that purified from interstitial cystitis urine. Purified antiproliferative factor specifically inhibited HB-EGF production by bladder epithelial cells in vitro, and the effect of interstitial cystitis urine or purified antiproliferative factor on bladder cell proliferation was inhibited by recombinant human HB-EGF in a dose dependent manner. Similar to urine HB-EGF, serum HB-EGF was also significantly lower in interstitial cystitis cases than in controls.
Conclusions:
Bladder epithelial abnormalities in interstitial cystitis may be caused by a negative autocrine growth factor that inhibits cell proliferation by down-regulating HB-EGF production. Furthermore, decreased levels of urine and serum HB-EGF indicate that interstitial cystitis may be a urinary tract manifestation of a systemic disorder.
References
- 1 :
Epidemiology of interstitial cystitis: 2 . In: Interstitial Cystitis. Edited by . London: Springer-Verlag1990: 29. Google Scholar - 2 : Interstitial cystitis. A patient’s perspective. Urol Clin North Am1994; 21: 1. Google Scholar
- 3 : Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn1975; 64: 75. Google Scholar
- 4 : Epidemiology of interstitial cystitis: a population based study. J Urol1999; 161: 549. Link, Google Scholar
- 5 : Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol1990; 143: 1118. Link, Google Scholar
- 6 : Chronic ulcerating interstitial cystitis (Hunner’s ulcer). Arch Pathol1972; 93: 76. Google Scholar
- 7 : Current findings and future research avenues in the study of interstitial cystitis. Urol Clin North Am1994; 21: 163. Google Scholar
- 8 : The etiology of interstitial cystitis. Urol Clin North Am1994; 21: 21. Google Scholar
- 9 : Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol1996; 156: 2073. Link, Google Scholar
- 10 : A diagnostic in vitro assay for interstitial cystitis. Urology1998; 52: 974. Google Scholar
- 11 : Antiproliferative activity is present in bladder but not renal pelvic urine from interstitial cystitis patients. J Urol1999; 162: 1487. Abstract, Google Scholar
- 12 : Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol1997; 158: 1983. Link, Google Scholar
- 13 : A hypothesis for the etiology of interstitial cystitis based upon inhibition of bladder epithelial repair. Med Hypotheses1998; 51: 79. Google Scholar
- 14 : Diagnostic criteria for research studies (interstitial cystitis). Am J Kidney Dis1999; 13: 353. Google Scholar
- 15 : Culture and characterization of normal epithelium from cystoscopic biopsies of human bladder. In Vitro Cell Dev Biol Anim1993; 29A: 908. Google Scholar
- 16 Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd International Symposium on Insulin-like Growth Factors. Endocrinology1995; 136: 816. Google Scholar
- 17 : Protein measurement with the Folin phenol reagent. J Biol Chem1951; 193: 265. Crossref, Medline, Google Scholar
- 18 : Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in pediatric patients. J Invest Dermatol1996; 106: 49. Google Scholar
- 19 : Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci U S A1993; 90: 3889. Google Scholar
- 20 : Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J Clin Invest1995; 96: 1018. Google Scholar
- 21 : Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest1997; 99: 1028. Crossref, Medline, Google Scholar
- 22 : The natural history of interstitial cystitis: a survey of 374 patients. J Urol1993; 149: 465. Link, Google Scholar
- 23 : The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology1997; 49: 64. Crossref, Medline, Google Scholar
- 24 : Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. J Clin Invest1997; 99: 2128. Google Scholar
- 25 : Transforming growth factor-alpha (TGF-alpha) expression during acute renal failure. J Am Soc Nephrol1996; 7: 1658. Google Scholar
- 26 : Reduced preproEGF mRNA and decreased EGF excretion in ARF. Kidney Int1989; 36: 810. Google Scholar
- 27 : Differential mRNA expression of insulin-like growth factor system during renal injury and hypertrophy. Am J Physiol1995; 269: F817. Google Scholar
- 28 : The gene for heparin-binding epidermal growth factor-like growth factor is stress-inducible: its role in cerebral ischemia. J Cereb Blood Flow Metab1999; 19: 307. Google Scholar
- 29 : Characterization of distinct functions for growth factors in murine transitional epithelial cells in primary organotypic culture. Exp Cell Res1994; 214: 510. Crossref, Medline, Google Scholar
- 30 : Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ1998; 9: 505. Google Scholar
- 31 : Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-beta receptor in mink lung epithelial cells. J Biol Chem1999; 274: 6711. Google Scholar
- 32 : Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev1995; 16: 3. Google Scholar
- 33 : Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J1997; 16: 1268. Google Scholar
- 34 : ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4. Proc Natl Acad Sci U S A1998; 95: 6809. Google Scholar
From the Divisions of Infectious Diseases and Nephrology, Department of Medicine, University of Maryland School of Medicine and Research Service, Department of Veterans Affairs Medical Center, Baltimore, Maryland
